...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems

If I recall, they took questions from us poor retail investors at the last AGM.

Share
New Message
Please login to post a reply